Skip to content

Interest Expense at other companies

Baxter International logo
Baxter InternationalBAX
-$12M+29.4%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$354M+16.8%
ADMA Biologics logo
ADMA BiologicsADMA
$2.1M+6.3%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$5.12M-20.8%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$1.98M+17.3%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$1.38M

Segments

By segment

See full
Reportable Segment-$7.22M

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-37.3%
Enterprise value$333.06M+6.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpense.

The official record: Lifecore Biomedical, Inc.’s 10-K, filed March 20, 2024, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s interest expense?
Lifecore Biomedical, Inc. (LFCR) reported interest expense of $3.93M in Q1 2023.
How has Lifecore Biomedical, Inc.'s interest expense changed year-over-year?
Lifecore Biomedical, Inc.'s interest expense increased by 135.0% year-over-year, from $1.67M to $3.93M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.